TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

Title
TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
Authors
Keywords
Breast cancer, Apoptosis, Small interfering RNAs, Cell cycle and cell division, Immunohistochemistry techniques, Biopsy, Cell staining, Prognosis
Journal
PLoS One
Volume 8, Issue 5, Pages e63712
Publisher
Public Library of Science (PLoS)
Online
2013-05-21
DOI
10.1371/journal.pone.0063712

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started